Clot-buster meds and mechanical retrieval found to equally reduce disability from some strokes

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical treatment (including clot-busting medication if indicated) alone, according to research presented today at the American Stroke Association’s International Stroke Conference 2025.

AI tool helps find life-saving medicine for rare disease

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman’s disease (iMCD). This rare disease has an especially poor survival rate and few treatment options. The patient could be the first of many to have their lives saved by an AI prediction system, which could potentially apply to other rare conditions.

Light-activated compound offers hope for overcoming drug resistance in cancer treatment

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using light. Professors Tae-Hyuk Kwon and Duyoung Min from the Department of Chemistry at UNIST, alongside Professor Taiho Park from POSTECH, have created a photoreactive compound capable of suppressing autophagy in cancer cells—one of the key mechanisms contributing to resistance against anticancer therapies.

Stress caused by war in Ukraine can affect children’s eating behavior

Professor of Nutrition Maijaliisa Erkkola’s research group investigated the prevalence of disruptions in eating behavior in children living in Ukraine in cooperation with the O.M. Marzieiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine. A total of 4,854 parents participated in the survey. The findings are published in the journal Maternal & Child Nutrition.